AstraZeneca (AstraZeneca) Total Tax Payable

: $2,076 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

AstraZeneca's Total Tax Payable for the quarter that ended in Dec. 2023 was $2,076 Mil.

AstraZeneca's quarterly Total Tax Payable declined from Jun. 2023 ($1,200 Mil) to Sep. 2023 ($1,163 Mil) but then increased from Sep. 2023 ($1,163 Mil) to Dec. 2023 ($2,076 Mil).

AstraZeneca's annual Total Tax Payable declined from Dec. 2021 ($1,379 Mil) to Dec. 2022 ($1,364 Mil) but then increased from Dec. 2022 ($1,364 Mil) to Dec. 2023 ($2,076 Mil).

AstraZeneca Total Tax Payable Historical Data

The historical data trend for AstraZeneca's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

1,684.00

1,517.00

1,379.00

1,364.00

2,076.00

AstraZeneca Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Tax Payable	Get a 7-Day Free Trial															1,364.00	1,203.00	1,200.00	1,163.00	2,076.00

AstraZeneca Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

AstraZeneca Total Tax Payable Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (AstraZeneca) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.